常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.68/-3.50
|
企業價值
278.43M
|
資產負債 |
每股賬面淨值
-0.10
|
現金流量 |
現金流量率
--
|
損益表 |
收益
26.00M
|
每股收益
0.32
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The companyleverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. |